Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine if Tetrix Cream,, when applied to the skin lesions on patients with contact dermatitis, slows or interferes with the healing of the lesions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | Twice daily topical application |
|
| 2 | Placebo Comparator | Twice daily topical application |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tetrix | Device | Twice daily topical application |
| |
| Tetrix |
| Measure | Description | Time Frame |
|---|---|---|
| Clearing of signs and symptoms of contact dermatitis | 10 days after induction of lesion and start of treatment |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joseph Fowler, MD | Dermatology Specialists, LLC | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dermatology Specialists, LLC | Louisville | Kentucky | 40202 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
Twice daily topical application |
|